ACRS Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

$10.37  -0.14 (-1.29%)
As of 01/26/2022 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/07/2015
Outstanding shares:  61,227,333
Average volume:  491,076
Market cap:   $622,681,977
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYV2W40
Valuation   (See tab for details)
PE ratio:   -7.91
PB ratio:   2.97
PS ratio:   91.04
Return on equity:   -37.51%
Net income %:   -1,187.63%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy